» Articles » PMID: 16049571

Evidence for the Activity of Lamotrigine at 5-HT(1A) Receptors in the Mouse Forced Swimming Test

Overview
Specialty Psychiatry
Date 2005 Jul 29
PMID 16049571
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The antiepileptic drug lamotrigine is effective in the treatment of focal epilepsies. It is thought to act by inhibition of glutamate release through blockade of voltage-sensitive sodium channels and stabilization of the neuronal membrane. Lamotrigine is also effective in the treatment of mood disorders such as bipolar disorder. However, its exact mechanism of action in these conditions remains unclear. The aim of the present study was to evaluate the antidepressant-like effect of lamotrigine in a mouse model of depression, namely the forced swimming test (FST). Association studies using specific and nonspecific ligands acting on serotonin (5-hydroxytryptamine; 5-HT1) receptor subtypes were undertaken to evaluate the potential role of these receptors in the anti-immobility effect of lamotrigine.

Methods: The mouse FST was performed after single administration of lamotrigine. Subactive doses of lamotrigine were administered in association with subactive doses of the following 5-HT1 receptor agonists or antagonists: 8-hydroxy-2-(di-n-propilamino)-tetralin (8-OH-DPAT, a standard 5-HT(1A) receptor selective agonist), pindolol (a presynaptic and postsynaptic 5-HT(1A/1B) receptor antagonist), NAN-190 (a 5-HT(1A) receptor antagonist), RU 24969 (a 5-HT(1A/1B) receptor agonist) and anpirtoline (5-HT(1B) agonist).

Results: Lamotrigine impaired spontaneous locomotor activity at doses of 4 mg/kg or greater, and activity decreased by more than 50% at the 16 mg/kg dose. When administered alone, lamotrigine (8 and 16 mg/kg) decreased immobility time in the FST. Only 8-OH-DPAT (1 mg/kg), pindolol (32 mg/kg) and RU 24969 (0.5 mg/kg) enhanced the antidepressant-like effect of lamotrigine in the FST.

Conclusions: These results suggest that postsynaptic 5-HT(1A) receptors might be involved in the activity of lamotrigine. Furthermore, they demonstrate that lamotrigine more closely resembles valproate and carbamazepine than lithium, with the advantage of an anti-immobility effect in the mouse FST when administered on its own.

Citing Articles

Drugs with glutamate-based mechanisms of action in psychiatry.

Chrobak A, Siwek M Pharmacol Rep. 2024; 76(6):1256-1271.

PMID: 39333460 PMC: 11582293. DOI: 10.1007/s43440-024-00656-8.


Acute and chronic effects of oral administration of a medium-chain fatty acid, capric acid, on locomotor activity and anxiety-like and depression-related behaviors in adult male C57BL/6J mice.

Shoji H, Kunugi H, Miyakawa T Neuropsychopharmacol Rep. 2022; 42(1):59-69.

PMID: 34994529 PMC: 8919109. DOI: 10.1002/npr2.12226.


Neurogenesis and Neuroplasticity in Major Depression: Its Therapeutic Implication.

Bourin M Adv Exp Med Biol. 2021; 1305:157-173.

PMID: 33834400 DOI: 10.1007/978-981-33-6044-0_10.


Antidepressant and pro-motivational effects of repeated lamotrigine treatment in a rat model of depressive symptoms.

Scheggi S, Pelliccia T, Cuomo A, De Montis M, Gambarana C Heliyon. 2018; 4(10):e00849.

PMID: 30338306 PMC: 6190531. DOI: 10.1016/j.heliyon.2018.e00849.


Predictive Validity of Some Common Animal Models of Bipolar Disorder Using Lithium and Lamotrigine Therapy: An Attempt towards a Battery-Based Approach for the Evaluation of Mood Stabilizers.

Kumar M, Tripathi C, Verma V, Padhy B, Gulab Meshram G, Abhilash B Psychiatry Investig. 2016; 13(4):434-9.

PMID: 27482245 PMC: 4965654. DOI: 10.4306/pi.2016.13.4.434.


References
1.
Nixon M, Hascoet M, Bourin M, Colombel M . Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology (Berl). 1994; 115(1-2):59-64. DOI: 10.1007/BF02244752. View

2.
Artigas F, Perez V, Alvarez E . Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry. 1994; 51(3):248-51. DOI: 10.1001/archpsyc.1994.03950030084009. View

3.
Blier P, Bergeron R . Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol. 1995; 15(3):217-22. DOI: 10.1097/00004714-199506000-00011. View

4.
Artigas F, Romero L, De Montigny C, Blier P . Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci. 1996; 19(9):378-83. DOI: 10.1016/S0166-2236(96)10037-0. View

5.
Walden J, Hesslinger B, van Calker D, Berger M . Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder. Pharmacopsychiatry. 1996; 29(5):193-5. DOI: 10.1055/s-2007-979570. View